Tag Archives: Nuffield Department of Population Health: University of Oxford

No Safe or Protective Level of Alcohol Consumption? (BBC News / Lancet)

Posted on April 6, 2019 by Dementia and Elderly Care News

Summary Light-to-moderate drinking increases blood pressure and the risk of stroke. “I have always been reasonably convinced that moderate alcohol consumption was protective for cardiovascular disease, but now I am having my doubts”. Professor David Spiegelhalter: Winton Professor for the … Continue reading →

Posted in Acute Hospitals, BBC News, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Statistics, Stroke, Universal Interest | Tagged Alcohol, Alcohol Acetaldehyde and East Asian Flushing Syndrome, Alcohol Consumption, Alcohol Dehydrogenase (ADH), Alcohol-Attributable Deaths and Disease Burden, Alcohol-Related Deaths, Alcohol-Related Harm, Aldehyde Dehydrogenase (ALDH), Amenable Mortality, Attributable Disease Burden Due to Alcohol Use, Avoidable Mortality, Avoidable Premature Mortality, BBC Health News, Behavioural Risk Factors, British Heart Foundation, Cancer Research UK, Cardiovascular Disease, Cardiovascular Risk, Cardiovascular Risk Factors, Cardiovascular Risk Factors (CVRF), China, China Kadoorie Biobank, Chinese Academy of Medical Sciences, Chinese Academy of Medical Sciences (Beijing), Chinese Ministry of Science and Technology, Clinical Trial Service Unit and Epidemiological Studies Unit: University of Oxford, Common Genetic Variants in East Asian Populations (ALDH2-rs671 and ADH1B-rs1229984), Department of Epidemiology and Biostatistics: Peking University, Epidemiology, Epidemiology and Statistics, Gansu Provincial Center for Disease Control and Prevention (Lanzhou), Genetic Epidemiology, Genetic Epidemiology in East Asian Populations, Genetic Research, Genetic Risk Factors, Genotypic Determinants of Alcohol Intake, GlaxoSmithKline, Henan Center for Disease Control and Prevention (Zhengzhou), Kadoorie Charitable Foundation, Lancet, Lifestyle Risk Factors, Liuyang Center for Disease Control and Prevention (Changsha), Low Risk Drinking, Medical Research Council, Medical Research Council Integrative Epidemiology Unit: University of Bristol, Medical Research Council Population Health Research Unit: University of Oxford, Modifiable Risk Factors, Mortality Risk Factors, Nangang Center for Disease Control and Prevention (Harbin), National Natural Science Foundation of China, Nuffield Department of Population Health: University of Oxford, Overlapping Risk Factors, Oxford, Peking University, Peking University Health Science Center, Population Health, Population Health Sciences: University of Bristol, Prevention, Prevention Agenda, Professor Sir David Spiegelhalter: Winton Professor for the Public Understanding of Risk at University of Cambridge, Psychosocial and Lifestyle-Related Risk Factors, Public Health, Public Health Burden of Alcohol, Reducing Alcohol-Related Harm, Stroke Prevention, University of Bristol, University of Oxford, Vascular Risk Factors, Wellcome Trust, Zhejiang Provincial Center for Disease Control and Prevention (Hangzhou) | Leave a comment

Cardiovascular Health in Old Age Associated With Reduced Risk of Cognitive Decline and Dementia (NHS Choices / JAMA)

Posted on August 27, 2018 by Dementia and Elderly Care News

Summary Fresh evidence from France suggests that favourable cardiovascular health metrics – measured using the American Heart Association (AHA)’s Life’s Simple 7 Metrics tool – and higher cardiovascular health scores, are associated with a lower risk of developing dementia and … Continue reading →

Estimating the Global Economic Impact of Dementia (BMJ Open / ROADMAP Group)

Posted on January 29, 2018 by Dementia and Elderly Care News

Summary Further work is underway to determine the costs and resource utilisation arising from dementia of all types. The total estimation will cover the personal and societal costs incurred by patients, their families and carers, and by national and local … Continue reading →

Posted in Acute Hospitals, Charitable Bodies, Commissioning, Community Care, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Management of Condition, Models of Dementia Care, Nuffield Trust, Person-Centred Care, Personalisation, Quick Insights, Standards, Statistics, Systematic Reviews, UK, Universal Interest | Tagged Alzheimer Centre Limburg (Maastricht), Attributable Cost of Dementia, Biogen (Cambridge Massachusetts), BMJ Open, BMJ Publishing Group Ltd, Bodleian Health Care Libraries: University of Oxford, Burden of Dementia, Burden of Dementia (Statistics), Burden on Caregivers, Carer Burden in Dementia, Cost Drivers in Dementia, Cost of Dementia to Business, Counting the Cost, Department of Neurobiology Care Science and Society: Karolinska Institute, Department of Psychiatry and Neuropsychology: Maastricht University, Division of Neurogeriatrics: Karolinska Institute, Economic Impact of Dementia, Effective Public Health Practice Project (Quality Assessment Tool), Eli Lilly and Company, Family Caregivers, Financial Cost of Dementia, Financial Modelling, GE Healthcare Life Sciences (Amersham UK), Global Burden of Dementia, Global Head Health Economic Modelling and Methodology: Novartis Pharmaceutical AG, Global Impact of Dementia, Global Impact of Dementia: World Alzheimer Report 2015, Global Societal Economic Cost of Dementia, Health Economics Research Centre: University of Oxford, Hidden Costs of Dementia, Impact of Dementia (Statistics), Impact of Dementia on Care Services, Karolinska Institute, London School of Economics and Political Science, Maastricht University, Netherlands, Novartis Pharmaceutical AG (Basel), Nuffield Department of Population Health: University of Oxford, Oxford, Personal Social Services Research Unit: London School of Economics and Political Science, Real World Outcomes Across the Alzheimer's Disease Spectrum for Better Care: Multi-Modal Data Access Platform (ROADMAP), ROADMAP Group, School for Mental Health and Neurosciences: Alzheimer Centre Limburg, Social and Economic Impact of Dementia, Societal Costs of Dementia, Sweden, Switzerland, Systematic Literature Reviews, Systematic Reviews and Meta-Analyses, University of Oxford, Unpaid Caregivers (Carers), USA, Value and Access: Biogen, World Alzheimer Report 2015, Worldwide Costs of Dementia | Leave a comment

Development of Standardised Intervention Outcome Measures for Dementia Prevention (PLoS One / HTA)

Posted on July 25, 2017 by Dementia and Elderly Care News

Summary The following articles present work towards establishing a consensus on the most suitable outcomes to be measured when assessing “disease modification” (or the lack of it) in response to interventions intended to delay or prevent the progress of dementia. … Continue reading →

Posted in Alzheimer's Society, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Mental Health, Models of Dementia Care, Quick Insights, Standards, Systematic Reviews, UK | Tagged Activities of Daily Living (ADLs), Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog), Alzheimer's Society, Alzheimer’s Disease Clinical Trials, and Health Psychology: University College London, Assessment of Quality of Life, Aston Research Centre for Healthy Ageing: Aston University, Aston University, Bangor University, Biological Markers, Biomarkers, Brighton and Sussex Medical School, Cambridge Institute of Public Health: University of Cambridge, Camden and Islington NHS Foundation Trust, Cardiff University, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Public Health: Queen's University Belfast, Centre for Research in Primary and Community Care: University of Hertfordshire, Clinical Dementia Rating (CDR), Clinical Dementia Rating Scale, Core Outcome Measures in Effectiveness Trials, Dementia Quality of Life (DEMQOL), Dementia Quality of Life Measure, Dementia Services Development Centre Wales: Bangor University, Department of Psychiatry and Psychotherapy: Ludwig-Maximilians-Universität München, Department of Psychiatry and Psychotherapy: Technische Universität München, Department of Psychiatry: University of Cambridge, Disability Assessment for Dementia-DAD, Disease Modification, Disease Modification Trials, Disease-Modifying Trials in Mild-to-Moderate Dementia, Division of Psychiatry: University College London, Division of Psychology and Language Sciences: University College London, Drug Trials Failure Rate, Faculty of Health and Social Care: University of Hull, Faculty of Medicine: Imperial College London, Germany, Health Technology Assessment (HTA) Programme, Health Technology Assessment Study, Health Technology Assessments, Imperial College London, Institute of Brain Behaviour and Mental Health: University of Manchester, Institute of Health and Society: Newcastle University, Institute of Mental Health: University of Nottingham, International Consortium for Health Outcomes Measurement, Kings College London, Leeds Beckett University, Ludwig-Maximilians-Universität München, Magnetic Resonance Imaging (MRI), Measurement of Successes and Failures of Dementia Treatments, Measuring the Impact of Interventions to Reduce Alzheimer’s Disease, Mini Mental State Examination (MMSE), National Institute for Health Research (NIHR), National Institute for Health Research: Health Technology Assessment Programme, Neuropsychiatric Inventory (NPI), Neuropsychiatric Inventory (NPI) Agitation / Aggression Scale, Neuropsychiatric Inventory Agitation / Aggression Domain (NPI), Neuropsychiatric Symptoms, Neuropsychiatric Symptoms in People With Dementia, Neuroscience Research Centre - St. George's: University of London, Newcastle University, NIHR Health Technology Assessment (HTA) Programme, NIHR HTA: Health Technology Assessment Programme, North Thames CLAHRC, Norwich Medical School: University of East Anglia, Nuffield Department of Population Health: University of Oxford, Opportunities for Standardisation, Outcome Measures for Disease-Modifying Trials in Mild-to-Moderate Dementia, Outcome Validation, Oxford Health NHS Foundation Trust, Patient and Public Involvement (PPI), PenCLAHRC: University of Exeter Medical School, Personal Social Services Research Unit: University of Manchester, Potential Treatment for Alzheimer’s Disease, Queen's University Belfast, Research Department of Clinical Educational, Research Institute for the Care of Older People (RICE): University of Bath, ScHARR: University of Sheffield, School of Clinical Sciences: University of Bristol, School of Health and Community Studies: Leeds Beckett University, School of Healthcare Sciences: Cardiff University, School of Medicine: University of Southampton, School of Psychology: University of Exeter, School of Public Health: Imperial College London, sMRI (Structural Magnetic Resonance Imaging), Standardisation, Systematic Reviews and Meta-Analyses, Technische Universität München, United Kingdom, University College London, University of Bath, University of Bristol, University of Cambridge, University of East Anglia, University of Exeter, University of Exeter Medical School, University of Hertfordshire, University of Hull, University of London, University of Manchester, University of Nottingham, University of Oxford, University of Sheffield, University of Southampton, University of Warwick, Warwick Clinical Trials Research Unit: University of Warwick, Wolfson Centre for Age-Related Diseases: King’s College London | Leave a comment

Researchers Advise Use of Aspirin Immediately After Minor Strokes (BBC News / Lancet)

Posted on May 21, 2016 by Dementia and Elderly Care News

Summary The benefits of taking aspirin immediately after a mini or minor stroke, to prevent or limit harm, have been hugely under-estimated. Full Text Link Reference Mundasad, S. (2016). ‘Immediate aspirin’ advice for minor stroke. London: BBC Health News, May … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, National, Pharmacological Treatments, Quick Insights, Statistics, Stroke, UK, Universal Interest | Tagged Aspirin, Aspirin Reduces Risk and Severity of Early Recurrent Stroke After Ischaemic Stroke, Aspirin Reduces Risk and Severity of Early Recurrent Stroke After Transient Ischaemic Attack, Australia, BBC Health News, Benefits of Aspirin in Early Secondary Stroke Prevention, Department of Clinical Sciences: Lund University, Department of Neurology: Sir Charles Gairdner Hospital, Department of Neurology: University Duisburg-Essen, Department of Neurology: University Medical Center Utrecht, Early Secondary Stroke Prevention, Germany, Ischaemic Stroke, Julius Center for Health Sciences and Primary Care: University Medical Center Utrecht, Lancet, Lund University, Mini-Strokes, Minor Strokes, Netherlands, Non-Haemorrhagic Stroke, Nuffield Department of Clinical Neurosciences: University of Oxford, Nuffield Department of Population Health: University of Oxford, Oxford University, Poststroke Rehabilitation, Rudolph Magnus Institute for Neuroscience, School of Medicine and Pharmacology: University of Western Australia, Secondary Stroke Prevention, Section of Neurology: Lund University, Sir Charles Gairdner Hospital: Perth, Stroke Association, Stroke Care, Stroke Prevention, Stroke Prevention Research Unit: University of Oxford, Stroke Rehabilitation, Stroke Statistics, Sweden, Symptoms of Stroke and Mini-Stroke, Tony Rudd: National Clinical Director for Stroke at NHS England, Transient Ischaemic Attack (TIA), University Duisburg-Essen, University Medical Center Utrecht, University of Oxford, University of Western Australia, Western Australian Neuroscience Research Institute (WANRI) | Leave a comment

UK Stroke and Dementia Research: Under-Funding Persists (BMJ Open / Guardian)

Posted on April 15, 2015 by Dementia and Elderly Care News

Summary The levels of research funding upon cancer, coronary heart disease (CHD), dementia and stroke were compared, in relation to burden of each of these diseases in terms of their prevalence, disability adjusted life years and economic burden. This analysis … Continue reading →

Posted in Commissioning, For Researchers (mostly), In the News, National, NIHR, Parkinson's Disease, Statistics, Stroke, UK, Universal Interest | Tagged BMJ Open, Burden of Dementia, Burden of Disease, Cancer, Cognitive Function and Ageing Study, Coronary Heart Disease (CHD), Dementia Disability Adjusted Life Years, Dementia Research, Disability Adjusted Life Years (DALY), European Community Concerted Action on the Epidemiology and Prevention of Dementia (EURODEM), General Register Office for Scotland, Guardian, Health Economics Research Centre: University of Oxford, Mortality Statistics, National Institute for Health Research (NIHR), National Statistics, Northern Ireland Statistics & Research Agency, Nuffield Department of Population Health: University of Oxford, Office for National Statistics, Office for National Statistics (ONS), Resource Allocation to Brain Research in Europe (RABRE), Stroke and Dementia Research Under-Funding, Stroke Disease Disability Adjusted Life Years, UK Clinical Research Collaboration, UK Health Research Analysis, UK Health Research Funding, UK Medical Research Spending (2008 and 2012), UK Stroke and Dementia Research, Underfunding of Stroke Research, University of Oxford | Leave a comment

Apple-a-Day for the Over-50s: Comparative Proverb Assessment (BBC News / BMJ)

Posted on December 29, 2013 by Dementia and Elderly Care News

Summary There is evidence indicating that were everyone over the age of 50 to eat an apple a day then 8,500 deaths from heart attacks and strokes could be avoided every year in the UK. This would amount to as big … Continue reading →

Posted in BBC News, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, National, Non-Pharmacological Treatments, Nutrition, Patient Care Pathway, Practical Advice, Quick Insights, Statistics, UK, Universal Interest | Tagged An Apple a Day, Balanced Diet, BHF Health Promotion Research Group, BMJ, British Heart Foundation Health Promotion Research Group, Cardiovascular Disease, Cardiovascular Risk, Cholesterol Treatment Trialists, Comparative Proverb Assessments, Diet, Dietary Choices, Eating Well, Elderly Malnutrition, Epidemiology, Epidemiology and Statistics, Five Portions of Fruit and Vegetables a Day, Fruit and Vegetables, Healthy Behaviours, Healthy Lifestyles, Hydration and Nutrition, Improving Public Health, Lifestyle Factors, Modelling Research, Nuffield Department of Population Health: University of Oxford, Nutritional and Pharmaceutical Approaches to Prevention of Vascular Disease, Nutritional Care, Predictive Modelling, PRIME Model, Public Health, Statins, University of Oxford | Leave a comment

Tag Archives: Nuffield Department of Population Health: University of Oxford

Cardiovascular Health in Old Age Associated With Reduced Risk of Cognitive Decline and Dementia (NHS Choices / JAMA)

Researchers Advise Use of Aspirin Immediately After Minor Strokes (BBC News / Lancet)

UK Stroke and Dementia Research: Under-Funding Persists (BMJ Open / Guardian)

Apple-a-Day for the Over-50s: Comparative Proverb Assessment (BBC News / BMJ)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites